Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    MD bureau
    MD bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

      • Home
      • MD bureau

      Articles By : MD bureau

      CDSCO updates FAQs Drugs & Clinical Trial Rules 2019

      CDSCO updates FAQs Drugs & Clinical Trial Rules 2019

      MD bureau10 March 2020 1:50 PM IST
      New Delhi: Aimed at promoting clinical research in the country. Union Health Ministry notified the Drugs and Clinical Trials Rules, 2019 in the month...
      Alembic  Pharma bags USFDA nod for doxycycline hyclate tablets

      Alembic Pharma bags USFDA nod for doxycycline hyclate tablets

      MD bureau6 March 2020 9:15 AM IST
      Doxycycline hyclate tablets 20 mg have an estimated market size of USD 7 million for the 12-month period ending December 2019
      USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler

      USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler

      MD bureau24 Feb 2020 1:23 PM IST
      New Delhi: Noting that the drug firm USV does not seem to enjoy the dominant position in the portfolio of medicines that it sells and hence no case...
      Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

      Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

      MD bureau23 Feb 2020 11:45 AM IST
      New Delhi: In continuation of the series of directives that the FDC Division, Central Drugs Standard Control Organization (CDSCO), Directorate General...
      Sanofi joins forces with US Department of Health to advance a novel coronavirus vaccine

      Sanofi joins forces with US Department of Health to advance a novel coronavirus vaccine

      MD bureau19 Feb 2020 3:03 PM IST
      India: Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast...
      Price of 21 essential drugs went up  in 2019, Details

      Price of 21 essential drugs went up in 2019, Details

      MD bureau8 Feb 2020 2:03 PM IST
      "It was noted that the twenty-one scheduled formulations considered for upward price revision under para 19 of DPCO, 2013 are low priced drugs and...
      Cess of 5pc on imported medical devices to increase cost, reduce healthcare affordability: MTaI

      Cess of 5pc on imported medical devices to increase cost, reduce healthcare affordability: MTaI

      MD bureau3 Feb 2020 2:46 PM IST
      "A 5% cess on custom duties for import has been imposed on medical devices in the budget which will increase the cost of the imported medical...
      Shilpa Medicare launches breakthrough therapy lenvatinib mesylate under brand Lenshil in India

      Shilpa Medicare launches breakthrough therapy lenvatinib mesylate under brand Lenshil in India

      MD bureau3 Feb 2020 1:22 PM IST
      Shilpa Medicare shall launch lenvatinib, at a breakthrough price which is over 50% lower than the existing brand available in India. Prior to the...
      Coronavirus: Chemist confirms increase in sale of N95 mask in Bengaluru

      Coronavirus: Chemist confirms increase in sale of N95 mask in Bengaluru

      MD bureau3 Feb 2020 1:14 PM IST
      Confirming the increase in sales of the mask, a chemist owner Sangmesh, said, "We are selling masks daily. People are asking for an N95 mask but we...
      Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx

      Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx

      MD bureau2 Feb 2020 10:30 AM IST
      Boston: Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. recently announced...
      Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

      Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea

      MD bureau2 Feb 2020 10:00 AM IST
      Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) for a pre-filled syringe to administer Eylea® (aflibercept solution...
      Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

      Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

      MD bureau1 Feb 2020 10:15 AM IST
      New Delhi: Aurobindo Pharma on Friday said its joint venture firm Eugia Pharma Specialities has received approval from the US health regulator to...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok